Current Knowledge about CD3
CD20-expressing
CD3+CD20+ T cells
CNS
multiple sclerosis
pathogenesis
rituximab
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
18 Aug 2024
18 Aug 2024
Historique:
received:
24
05
2024
revised:
16
08
2024
accepted:
18
08
2024
medline:
31
8
2024
pubmed:
31
8
2024
entrez:
29
8
2024
Statut:
epublish
Résumé
Multiple sclerosis (MS) is a disease of the central nervous system (CNS) characterized by inflammation and autoimmune responses. This review explores the participation of T cells, particularly certain CD3
Identifiants
pubmed: 39201672
pii: ijms25168987
doi: 10.3390/ijms25168987
pii:
doi:
Substances chimiques
Antigens, CD20
0
CD3 Complex
0
Rituximab
4F4X42SYQ6
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM